Back to search

Article

Baricitinib improves the efficacy of nintedanib for the treatment of idiopathic pulmonary fibrosis

2023-10-12

Abstract excerpt

<title>Abstract</title><p><bold>Background:</bold>Nintedanib has been approved to treat idiopathic pulmonary fibrosis (IPF) but with limited efficacy, while targeting Janus Kinases (JAK)/ Transducer and signal activator of transcription (STAT) has emerged as a feasible strategy in this disease recently. However, the therapeutic potential of intervening in both pathways is rarely defined, prompting us to investigat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e574b51d-07c2-5736-aab7-3dbb11715aa5
DOI
10.21203/rs.3.rs-3339636/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Baricitinib improves the efficacy of nintedanib for the treatment of idiopathic pulmonary fibrosisDOI 10.21203/rs.3.rs-3339636/v1
Nifuroxazide Ameliorates Pulmonary Fibrosis By Blocking Myofibroblast Genesis And Stat3 Activation: A Drug Repurposing StudySemantic proximity
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.Semantic proximity
Inhibition of fibrosis with multi-agent therapy in pulmonary fibrosis: Results of a drug library screeningSemantic proximity
Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity
Zanubrutinib Attenuated Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling PathwaySemantic proximity
Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental VerificationSemantic proximity
Expression profiles of nintedanib-targeting molecules in progressive fibrotic interstitial lung diseases (non-IPF-PF) and IPFSemantic proximity
Repurposing Nintedanib for Pathological Cardiac Remodeling and DysfunctionSemantic proximity
Transcriptomic analysis reveals lipid metabolism and macrophage involvement associated with nintedanib treatment in a rat bleomycin modelSemantic proximity
A noble TGFβ biogenesis inhibitor exhibits both potent anti-fibrotic and anti-inflammatory capabilitiesSemantic proximity
Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathwaySemantic proximity
Codonopsis radix improves bleomycin-induced idiopathic pulmonary fibrosis by regulating TGF-β1/Smad signaling pathway and inhibiting fibroblast differentiation and proliferationSemantic proximity
Select a neighboring publication to make it the new centre.